During the past decade, Ålesund Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 2 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ålesund Hospital" #1 sponsor was "Norwegian University of Science and Technology" with 15 trials, followed by "Helse Møre og Romsdal HF" with 5 trials sponsored, "Oslo University Hospital" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "St. Olavs Hospital" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ålesund Hospital" #1 collaborator was "Alesund Hospital" with 20 trials as a collaborator, "St. Olavs Hospital" with 16 trials as a collaborator, "Haukeland University Hospital" with 12 trials as a collaborator, "University Hospital of North Norway" with 11 trials as a collaborator and "Helse Nord-Trøndelag HF" with 9 trials as a collaborator. Other collaborators include 163 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Ålesund Hospital" are "Stroke" (4 trials), "Cardiovascular Diseases" (2 trials), "Crohn Disease" (2 trials), "Crohn's Disease" (2 trials) and "Healthy Volunteers" (2 trials). Many other conditions were trialed in "Ålesund Hospital" in a lesser frequency.

Most popular intervention types in "Ålesund Hospital" are "Drug" (25 trials), "Other" (8 trials), "Behavioral" (7 trials), "Biological" (6 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Guselkumab" (3 trials), "Atezolizumab" (2 trials), "Control" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ålesund Hospital" are 50 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ålesund Hospital". undefined are not yet recruiting, 21 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Ålesund Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ålesund Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 21 trials that are defined as “Not Applicable".